Periodic Reporting for period 1 - LiverTarget (Next generation advanced RNA inhibition therapy to treat cardiometabolic disease)

Cardiovascular disease and its atherosclerotic complications of heart attack and stroke constitute the number-one cause of death in the world, affecting both genders and becoming more and more prevalent. For instance, in Europe, just Coronary Heart Disease (CHD) accounts for...